Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H (3) receptor antagonists.

Hancock, A A; Bitner, R S; Krueger, K M; Otte, S; Nikkel, A L; Fey, T A; Bush, E N; Dickinson, R W; Shapiro, R; Knourek-Segel, V; Droz, B A; Brune, M E; Jacobson, P B; Cowart, M D; Esbenshade, T A

Hancock, A A; Bitner, R S; Krueger, K M; Otte, S; Nikkel, A L; Fey, T A; Bush, E N; Dickinson, R W; Shapiro, R; Knourek-Segel, V; Droz, B A; Brune, M E; Jacobson, P B; Cowart, M D; Esbenshade, T A.

Affiliation

Hancock AA; Department R4MN, AP9A-3, Abbott Laboratories, Global Pharmaceutical Research and Development, 100 Abbott Park Road, Abbott Park, IL, 60064-6125, USA.

Inflamm Res ; 55 Suppl 1: S42-4, 2006 Apr.

Article in En | MEDLINE | ID: mdl-16547814

Subject(s)

Anti-Obesity Agents/pharmacology; Cognition/drug effects; Histamine Antagonists/pharmacology; Receptors, Histamine H3/drug effects; Animals; Brain/drug effects; Brain/metabolism; Ligands; Male; Mice; Proto-Oncogene Proteins c-fos/metabolism; Rats; Rats, Sprague-Dawley

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cognition / Receptors, Histamine H3 / Anti-Obesity Agents / Histamine Antagonists Limits: Animals Language: En Journal: Inflamm Res Year: 2006 Document type: Article

Search on Google

XML

PubMed Links